Molecular subtyping of small cell lung cancer.
Liang J, Guan X, Bao G, Yao Y, Zhong X.
Semin Cancer Biol. 2022 Nov;86(Pt 2):450-462. doi: 10.1016/j.semcancer.2022.05.010. Epub 2022 May 21.
Pulmonary Large Cell Neuroendocrine Carcinoma.
Yang L, Fan Y, Lu H.
Pathol Oncol Res. 2022 Oct 11;28:1610730. doi: 10.3389/pore.2022.1610730. eCollection 2022.
Malignant perivascular epithelioid cell tumor of the lung synchronous with a primary adenocarcinoma: one case report and review of the literature.
Zhao J, Teng H, Zhao R, Ding W, Yu K, Zhu L, Zhang J, Han Y.
BMC Cancer. 2019 Mar 15;19(1):235. doi: 10.1186/s12885-019-5383-0.
Inflammatory myofibroblastic tumor of the lung.
Khatri A, Agrawal A, Sikachi RR, Mehta D, Sahni S, Meena N.
Adv Respir Med. 2018;86(1):27-35. doi: 10.5603/ARM.2018.0007.
Malignant pleural effusions because of lung cancer.
Porcel JM.
Curr Opin Pulm Med. 2016 Jul;22(4):356-61. doi: 10.1097/MCP.0000000000000264.
Glomus tumor of uncertain malignant potential of the lung: a case report and review of literature.
Wan PZ, Han Q, Wang EH, Lin XY.
Int J Clin Exp Pathol. 2015 Nov 1;8(11):15402-6. eCollection 2015.
[Advances in the Study of Tumor-associated Macrophages in Lung Cancer].
Qiao Y, Fu E.
Zhongguo Fei Ai Za Zhi. 2022 Jan 20;25(1):34-39. doi: 10.3779/j.issn.1009-3419.2021.102.49.
Development of new techniques and clinical applications of liquid biopsy in lung cancer management.
Chen K, He Y, Wang W, Yuan X, Carbone DP, Yang F.
Sci Bull (Beijing). 2024 May 30;69(10):1556-1568. doi: 10.1016/j.scib.2024.03.062. Epub 2024 Apr 1.
Significance of tumor-associated autoantibodies in the early diagnosis of lung cancer.
Du Q, Yu R, Wang H, Yan D, Yuan Q, Ma Y, Slamon D, Hou D, Wang H, Wang Q.
Clin Respir J. 2018 Jun;12(6):2020-2028. doi: 10.1111/crj.12769. Epub 2018 Feb 15.
Advances in Exosome Research in the Management of Lung Cancer.
Shen H, Cao D, Zhang X.
Curr Top Med Chem. 2023;23(10):921-930. doi: 10.2174/1568026623666230504101208.
